The past 15 years has seen a rapid increase in the introduction of drug-device combination products driven by a move towards more self-medication. This has included the adoption of a relatively small number of electronic drug delivery devices but with the arrival of low cost wireless connectivity, there is an opportunity to accelerate the adoption of new technology and introduce digital services that can provide better patient support, either by enabling patients to take more control of their medication and disease management to provide remote access to healthcare support. The Covid situation has impacted us in many ways over the past 18 months but for medication and disease management, it has demonstrated both the need and the potential for telemedicine and remote monitoring.
A key aspect in improving disease management is the need to address medication non-adherence – it is estimated that for many medications, adherence is less than 50%. Connected drug delivery devices provide a particular opportunity to gather medication use data in near real time that can be used to provide better patient support and also to capture the data into healthcare management systems. Medication non-adherence is principally a behavioral issue that requires appropriate interventions. The combination of behavioral science and connected health can offer a promising route forward whether to provide better, actionable data to support current interventions such as patent support programmes or to develop digital interventions such as patient facing apps.
The aim of this workshop is to facilitate a practical and hands-on approach to the development of digital combination products with the active participation of attendees and the sharing of practical experience. We will base the workshop on a case study that focusses on a digitally enable patient support programme and look at this form the perspectives of the design and introduction of behavioral interventions, the commercial opportunity for digital health and the challenges that need to be address in areas such as cyber security.
We look forward to welcoming you to the workshop!
The Workshop Lead
Iain Simpson, Phillips Medisize – a Molex Company
Iain Simpson, Phillips Medisize – A Molex Company - Workshop Lead
Quentin Le Masne, Merck KGaA
Scott Mullen, Ascendis Pharma
Paul Upham, Roche/Genentech